Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,012 total articles

Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration

Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration

Fortitude Mining Holdings has acquired approximately 9.4% ownership in HeartSciences by purchasing $1 million worth of common stock at a 22% premium, providing HeartSciences with additional working capital ahead of their proposed business combination. The transaction maintains the original merger terms and aims to strengthen HeartSciences' financia…

Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway

Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway

Cosmos Health Inc. announced its Q2 and H1 2026 financial results, achieving record revenues of $19.0 million in Q2 and $36.9 million in H1, reflecting growth of 29% and 30% respectively. Adjusted gross profit increased 58% with expanded margins, operating expenses grew well below revenue, and the company decreased liabilities by 13% while increasi…

InterCure Ltd. Announces 1-for-5 Reverse Share Split

InterCure Ltd. Announces 1-for-5 Reverse Share Split

InterCure Ltd. (Nasdaq: INCR) announced a one-for-five reverse share split aiming to increase its share price to meet Nasdaq's minimum $1.00 bid requirement and maintain its listing on the Nasdaq Global Market. The split, approved by shareholders, will reduce outstanding shares from approximately 59.2 million to 11.8 million and adjust authorized c…

Ghost Face Joins Angry Orchard’s Limited-Edition Thriller Variety Pack in New Scream Franchise Collaboration

Ghost Face Joins Angry Orchard’s Limited-Edition Thriller Variety Pack in New Scream Franchise Collaboration

Angry Orchard, a leading hard cider brand, announced a Halloween-themed collaboration with the Scream franchise and Fun World, featuring the limited-edition Thriller Variety Pack with new cider flavors inspired by the iconic Ghost Face character. The pack includes innovative packaging and new flavors launching nationwide, enhancing seasonal offerin…

Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth

Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth

Intelligent Bio Solutions Inc. reported a 38% year-over-year revenue increase to $4.2 million for fiscal 2026, driven by a 22% growth in reader installed base and 35% growth in consumable cartridge sales. Gross margin expanded by 778 basis points to 48.63%, supported by lower-cost manufacturing and optimized product mix. The company advanced its FD…

Jet.AI Highlights Strategic Value of AI Data Center Portfolio Amid Surging Demand for Powered Land and Early-Stage Infrastructure Assets

Jet.AI Highlights Strategic Value of AI Data Center Portfolio Amid Surging Demand for Powered Land and Early-Stage Infrastructure Assets

Jet.AI Inc. highlights its strategic focus on acquiring and developing powered, shovel-ready land for AI data centers across North America, addressing a critical supply bottleneck in the AI infrastructure buildout. The company's portfolio includes over 1 GW of potential capacity across key sites in Canada and the US, positioning Jet.AI to capture h…

Cycurion Extends Patent Protection on VuLink®, the Cross-Activation Technology That Automatically Records and Syncs Every Camera on Scene, Never Missing an Event

Cycurion Extends Patent Protection on VuLink®, the Cross-Activation Technology That Automatically Records and Syncs Every Camera on Scene, Never Missing an Event

Cycurion, Inc. announced that the U.S. Patent and Trademark Office granted them a new patent extending protection for their VuLink® cross-activation technology. This system enables automatic, simultaneous recording across multiple compatible body and vehicle cameras, synchronizing footage to capture every event without lapses. The patent strengthen…

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

Teva Pharmaceutical Industries Ltd. announced the FDA has accepted the New Drug Application for Ecopipam, a first-in-class D1 dopamine receptor antagonist for pediatric Tourette syndrome, granting it Priority Review with a PDUFA date in early 2027. Ecopipam represents the first new treatment option for pediatric Tourette syndrome in over a decade a…

Trekor Updates Status of Aley Niobium and Strengthens Project Team

Trekor Updates Status of Aley Niobium and Strengthens Project Team

Trekor Metals Limited announced significant progress in its Aley niobium project, including a proprietary flotation process that increases niobium recovery and reduces reagent use, successfully producing market-grade ferroniobium. The company has appointed Steve Sparkowich as Director to advance technical and commercial development, aiming to posit…

InterDigital to Present at 2026 Midwest IDEAS Conference

InterDigital to Present at 2026 Midwest IDEAS Conference

InterDigital, Inc., a global leader in wireless, video, and AI technology research and development, announced it will present at the 2026 Midwest IDEAS Conference. The presentation will showcase the company's ongoing innovation in foundational technologies that drive connected and immersive experiences across communications and entertainment sector…

Progressive Reports July 2026 Results

Progressive Reports July 2026 Results

The Progressive Corporation reported July 2026 financial results showing a 5% increase in net premiums written and earned compared to July 2025, reflecting growth in personal and commercial lines. However, net income declined by 12%, and the combined ratio worsened by 1.5 points. Policies in force increased by 7%, driven mainly by gains in auto ins…

MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies

MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies

MaxCyte, Inc. has launched two new off-target nomination assays, CHANGE-seq-BE™ and ONE-seq-BE™, as part of its SeQure™ service platform. These assays provide sensitive and orthogonal methods to identify off-target sites in genome editing therapies involving adenine and cytosine base editors. This innovation supports therapeutic developers by enhan…

SKK Holdings Awarded Six New Horizontal Directional Drilling and Utility Works Contracts in Singapore Valued at Up to US$26.6 Million (S$34.1 Million)

SKK Holdings Awarded Six New Horizontal Directional Drilling and Utility Works Contracts in Singapore Valued at Up to US$26.6 Million (S$34.1 Million)

SKK Holdings announced six new horizontal directional drilling and utility works contracts in Singapore valued at up to $26.6 million, the largest block of new work to date, reinforcing its position in Singapore's infrastructure market. Concurrently, SKK is progressing on a $258.8 million acquisition of Rantizo's drone-based technology assets, aimi…

NRC Commences Readiness Assessment of Terra Innovatum’s SOLO™ Construction Permit Application (CPA)

NRC Commences Readiness Assessment of Terra Innovatum’s SOLO™ Construction Permit Application (CPA)

Terra Innovatum Global N.V. (NASDAQ: NKLR) announced that the U.S. Nuclear Regulatory Commission (NRC) has initiated the first phase of a readiness assessment of the company's planned Construction Permit Application (CPA) for its SOLO™ Micro-Modular Reactor (SMR). This early review focuses on environmental and safety documentation and aims to ident…